标题
Systemic treatment of soft-tissue sarcoma—gold standard and novel therapies
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume 11, Issue 4, Pages 187-202
出版商
Springer Nature
发表日期
2014-03-18
DOI
10.1038/nrclinonc.2014.26
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Adherence to treatment guidelines for primary sarcomas affects patient survival: a side study of the European CONnective TIssue CAncer NETwork (CONTICANET)
- (2013) C. R. Rossi et al. ANNALS OF ONCOLOGY
- Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience
- (2013) Alice Levard et al. BMC CANCER
- Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic review
- (2013) Sheetal Sharma et al. BMC CANCER
- Sorafenib in patients with progressive epithelioid hemangioendothelioma
- (2013) Christine Chevreau et al. CANCER
- Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
- (2013) Giovanni Germano et al. CANCER CELL
- SRC Signaling Is Crucial in the Growth of Synovial Sarcoma Cells
- (2013) S. Michels et al. CANCER RESEARCH
- Response to chemotherapy of solitary fibrous tumour: A retrospective study
- (2013) S. Stacchiotti et al. EUROPEAN JOURNAL OF CANCER
- The diversity of soft tissue tumours withEWSR1gene rearrangements: a review
- (2013) Cyril Fisher HISTOPATHOLOGY
- Expression and clinical relevance of MET and ALK in Ewing sarcomas
- (2013) Emmy D.G. Fleuren et al. INTERNATIONAL JOURNAL OF CANCER
- Multicenter phase II study of everolimus in patients with metastatic or recurrent bone and soft-tissue sarcomas after failure of anthracycline and ifosfamide
- (2013) Changhoon Yoo et al. INVESTIGATIONAL NEW DRUGS
- Cediranib for Metastatic Alveolar Soft Part Sarcoma
- (2013) Shivaani Kummar et al. JOURNAL OF CLINICAL ONCOLOGY
- Results of an International Randomized Phase III Trial of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus Versus Placebo to Control Metastatic Sarcomas in Patients After Benefit From Prior Chemotherapy
- (2013) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With Advanced CDK4-Amplified Well-Differentiated or Dedifferentiated Liposarcoma
- (2013) Mark A. Dickson et al. JOURNAL OF CLINICAL ONCOLOGY
- Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
- (2013) John J Bissler et al. LANCET
- Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial
- (2013) Gary K Schwartz et al. LANCET ONCOLOGY
- Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
- (2013) Yael P Mossé et al. LANCET ONCOLOGY
- Oncolytic viruses as therapeutic cancer vaccines
- (2013) David L Bartlett et al. Molecular Cancer
- Hepatotoxicity with Combination of Vemurafenib and Ipilimumab
- (2013) Antoni Ribas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Paediatric and adolescent alveolar soft part sarcoma: A joint series from European cooperative groups
- (2013) D. Orbach et al. PEDIATRIC BLOOD & CANCER
- The Influence of Primary Site on Outcomes in Leiomyosarcoma
- (2012) Mohamad Farid et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Tumors With EWSR1-CREB1 and EWSR1-ATF1 Fusions
- (2012) Khin Thway et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Diagnostic Utility of p16, CDK4, and MDM2 as an Immunohistochemical Panel in Distinguishing Well-differentiated and Dedifferentiated Liposarcomas From Other Adipocytic Tumors
- (2012) Khin Thway et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Subtyping soft tissue sarcomas for treatment approaches
- (2012) I. Judson et al. ANNALS OF ONCOLOGY
- Sunitinib malate in solitary fibrous tumor (SFT)
- (2012) S. Stacchiotti et al. ANNALS OF ONCOLOGY
- An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas
- (2012) M. Agulnik et al. ANNALS OF ONCOLOGY
- A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies
- (2012) Michael J. Pishvaian et al. CANCER
- Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors
- (2012) Andrew J. Wagner et al. CANCER
- Deconstruction of the SS18-SSX Fusion Oncoprotein Complex: Insights into Disease Etiology and Therapeutics
- (2012) Le Su et al. CANCER CELL
- PARP-1 Inhibition as a Targeted Strategy to Treat Ewing's Sarcoma
- (2012) J. C. Brenner et al. CANCER RESEARCH
- SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: A study from the Japanese Musculoskeletal Oncology Group
- (2012) Satoshi Kawaguchi et al. CANCER SCIENCE
- The Cyclin-Dependent Kinase Inhibitor Flavopiridol Potentiates Doxorubicin Efficacy in Advanced Sarcomas: Preclinical Investigations and Results of a Phase I Dose-Escalation Clinical Trial
- (2012) J. J. Luke et al. CLINICAL CANCER RESEARCH
- Phase I Studies of Sirolimus Alone or in Combination with Pharmacokinetic Modulators in Advanced Cancer Patients
- (2012) E. E. W. Cohen et al. CLINICAL CANCER RESEARCH
- Prognostic Significance of AKT/mTOR and MAPK Pathways and Antitumor Effect of mTOR Inhibitor in NF1-Related and Sporadic Malignant Peripheral Nerve Sheath Tumors
- (2012) M. Endo et al. CLINICAL CANCER RESEARCH
- A retrospective analysis of antitumour activity with trabectedin in translocation-related sarcomas
- (2012) Axel Le Cesne et al. EUROPEAN JOURNAL OF CANCER
- Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: A 10-year single institution retrospective study
- (2012) Nicole J. Look Hong et al. EUROPEAN JOURNAL OF CANCER
- High grade undifferentiated uterine sarcoma: Surgery, treatment, and survival outcomes
- (2012) Edward J. Tanner et al. GYNECOLOGIC ONCOLOGY
- Recent developments in uterine mesenchymal neoplasms
- (2012) Sarah Chiang et al. HISTOPATHOLOGY
- Outcome and Prognostic Factors in Endometrial Stromal Tumors: A Rare Cancer Network Study
- (2012) Ulrike Schick et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors
- (2012) Walter J. Jessen et al. JOURNAL OF CLINICAL INVESTIGATION
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
- (2012) Winette TA van der Graaf et al. LANCET
- Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial
- (2012) Penella J Woll et al. LANCET ONCOLOGY
- Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study
- (2012) Isabelle Ray-Coquard et al. LANCET ONCOLOGY
- The cancer-testis antigen NY-ESO-1 is highly expressed in myxoid and round cell subset of liposarcomas
- (2012) Jessica A Hemminger et al. MODERN PATHOLOGY
- Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model
- (2012) Elizabeth G Demicco et al. MODERN PATHOLOGY
- Randomized Multicenter and Stratified Phase II Study of Gemcitabine Alone Versus Gemcitabine and Docetaxel in Patients with Metastatic or Relapsed Leiomyosarcomas: A Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)
- (2012) P. Pautier et al. ONCOLOGIST
- Conventional anthracycline-based chemotherapy has limited efficacy in solitary fibrous tumour
- (2011) Anastasia Constantinidou et al. ACTA ONCOLOGICA
- High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial
- (2011) B. Bui-Nguyen et al. ANNALS OF ONCOLOGY
- Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network
- (2011) S. Stacchiotti et al. ANNALS OF ONCOLOGY
- Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect
- (2011) S. Stacchiotti et al. ANNALS OF ONCOLOGY
- Anticancer activity of stabilized palifosfamide in vivo
- (2011) Barry Jones et al. ANTI-CANCER DRUGS
- A phase 2 study of temsirolimus (CCI-779) in patients with soft tissue sarcomas
- (2011) Scott Okuno et al. CANCER
- Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas
- (2011) Antoine Italiano et al. CANCER
- Feasibility of metronomic oral cyclophosphamide plus prednisolone in elderly patients with inoperable or metastatic soft tissue sarcoma
- (2011) Olivier Mir et al. EUROPEAN JOURNAL OF CANCER
- A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites
- (2011) Costantino Errani et al. GENES CHROMOSOMES & CANCER
- Recurrence patterns and prognosis of endometrial stromal sarcoma and the potential of tyrosine kinase-inhibiting therapy
- (2011) X. Cheng et al. GYNECOLOGIC ONCOLOGY
- Trabectedin in advanced uterine leiomyosarcomas: A retrospective case series analysis from two reference centers
- (2011) Roberta Sanfilippo et al. GYNECOLOGIC ONCOLOGY
- A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: A gynecologic oncology group study
- (2011) Bradley J. Monk et al. GYNECOLOGIC ONCOLOGY
- Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
- (2011) Razelle Kurzrock et al. JOURNAL OF CLINICAL ONCOLOGY
- Preliminary Efficacy of the Anti-Insulin–Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma
- (2011) Heribert Juergens et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study
- (2011) Xavier García-del-Muro et al. JOURNAL OF CLINICAL ONCOLOGY
- Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular Lymphoma
- (2011) Stephen J. Schuster et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes
- (2011) Patrick Schöffski et al. LANCET ONCOLOGY
- Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
- (2011) Theonie Anastassiadis et al. NATURE BIOTECHNOLOGY
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Translocation t(7;19)(q22;q13)—a recurrent chromosome aberration in pseudomyogenic hemangioendothelioma?
- (2011) Domenico Trombetta et al. Cancer Genetics
- Bevacizumab for recurrent hemangioendothelioma
- (2010) Karolin Trautmann et al. ACTA ONCOLOGICA
- Solitary Fibrous Tumors of the Soft Tissues: Review of the Imaging and Clinical Features With Histopathologic Correlation
- (2010) Oliver J. Wignall et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Clinical outcome of leiomyosarcomas of vascular origin: comparison with leiomyosarcomas of other origin
- (2010) A. Italiano et al. ANNALS OF ONCOLOGY
- Impact of adjuvant treatment modalities on the management of patients with stages I-II endometrial stromal sarcoma
- (2010) G. G. Malouf et al. ANNALS OF ONCOLOGY
- Treatment with the mTOR inhibitor temsirolimus in patients with malignant PEComa
- (2010) A. Italiano et al. ANNALS OF ONCOLOGY
- A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region
- (2010) P A Cassier et al. BRITISH JOURNAL OF CANCER
- Combination mTOR and IGF-1R Inhibition: Phase I Trial of Everolimus and Figitumumab in Patients with Advanced Sarcomas and Other Solid Tumors
- (2010) R. Quek et al. CLINICAL CANCER RESEARCH
- The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor
- (2010) J. J. Manfredi GENES & DEVELOPMENT
- Clinical Activity of mTOR Inhibition With Sirolimus in Malignant Perivascular Epithelioid Cell Tumors: Targeting the Pathogenic Activation of mTORC1 in Tumors
- (2010) Andrew J. Wagner et al. JOURNAL OF CLINICAL ONCOLOGY
- Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials
- (2010) Piotr Rutkowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
- (2010) Jordi Barretina et al. NATURE GENETICS
- MET signalling: principles and functions in development, organ regeneration and cancer
- (2010) Livio Trusolino et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor
- (2010) James E. Butrynski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insulin-Like Growth Factor-I Regulation of Immune Function: A Potential Therapeutic Target in Autoimmune Diseases?
- (2010) T. J. Smith PHARMACOLOGICAL REVIEWS
- KDR Activating Mutations in Human Angiosarcomas Are Sensitive to Specific Kinase Inhibitors
- (2009) C. R. Antonescu et al. CANCER RESEARCH
- Clinical outcomes of extra-thoracic solitary fibrous tumours
- (2009) I.M. Cranshaw et al. EJSO
- Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas
- (2009) Stefan Sleijfer et al. EUROPEAN JOURNAL OF CANCER
- The efficacy of hormonal treatment for residual or recurrent low-grade endometrial stromal sarcoma. A retrospective study
- (2009) Taghride Dahhan et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study
- (2009) Martee L. Hensley et al. GYNECOLOGIC ONCOLOGY
- Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors
- (2009) Roisin O'Cearbhaill et al. GYNECOLOGIC ONCOLOGY
- Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules
- (2009) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model
- (2009) Rashmi Chugh et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
- (2009) Robert G. Maki et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
- (2009) Stefan Sleijfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Lenalidomide stops progression of multifocal epithelioid hemangioendothelioma including intracranial disease
- (2009) Ashley Sumrall et al. JOURNAL OF NEURO-ONCOLOGY
- Metastatic Hepatic Epithelioid Hemangioendothelioma in a Teenage Girl
- (2009) Alisha Kassam et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study
- (2009) David Olmos et al. LANCET ONCOLOGY
- Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors
- (2009) C. Forni et al. MOLECULAR CANCER THERAPEUTICS
- The nuts and bolts of AGC protein kinases
- (2009) Laura R. Pearce et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma
- (2008) Nabeel Pervaiz et al. CANCER
- Paclitaxel in patients with advanced angiosarcomas of soft tissue: A retrospective study of the EORTC soft tissue and bone sarcoma group
- (2008) M. Schlemmer et al. EUROPEAN JOURNAL OF CANCER
- Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study
- (2008) Nicolas Penel et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing KIT
- (2008) Charles D. Blanke et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting RAS and PI3K in lung cancer
- (2008) Julian Downward NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started